Martina Brandlhuber1, Christian Genzinger2, Bernhard Brandlhuber3, Wieland H Sommer1, Mario H Müller4, Martin E Kreis5. 1. Department of Radiology, Ludwig Maximilian University of Munich, Marchionini Str. 15, 81377, Munich, Germany. 2. Department of Anesthesiology, Ludwig Maximilian University of Munich, Marchionini Str. 15, 81377, Munich, Germany. 3. Department of Internal Medicine, Klinik Mühldorf am Inn, Krankenhausstraße 1, 84453, Mühldorf am Inn, Germany. 4. Department of Visceral Surgery, Vivantes Klinikum Neukölln, Rudower Straße 48, 12351, Berlin, Germany. 5. Department of General-, Visceral- and Vascular Surgery, Charité University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, Germany. martin.kreis@charite.de.
Abstract
PURPOSE: It is controversial whether patients fare better with conservative or surgical treatment in certain stages of acute diverticulitis (AD), in particular when phlegmonous inflammation or covered micro- or macro-perforation are present. The aim of this study was to determine long-term quality of life (QoL) for AD patients who received either surgery or conservative treatment in different stages. METHODS: We included patients treated for AD at the University Hospital Grosshadern, Munich, Germany, between January 1, 2000, and December 31, 2010. Patients were classified by the Hansen and Stock (HS) classification, the modified Hinchey classification, and the German classification of diverticular disease (CDD). Pre-therapeutic staging was based on multidetector computed tomography. Long-term QoL was assessed by the Cleveland Global Quality of Life (CGQL) questionnaire, the Short Form 36 (SF-36), and the Gastrointestinal Quality of Life Index (GIQLI). Data are mean ± SEM. RESULTS: Patients with phlegmonous AD (HS type 2a, Hinchey Ia and CDD 1b, respectively) had a better long-term QoL on the GIQLI when they were operated (78.5 ± 2.5 vs. 70.7 ± 2.1; p < 0.05). Patients with micro-abscess (CDD 2a) had a better long-term QoL on the GIQLI, CGQL, and the "Role Physical" scale of the SF-36 when they were not operated (GIQLI 86.9 ± 2.1 vs. 76.8 ± 1.0; p = 0.10; CGQL 82.8 ± 5.1 vs. 65.3 ± 11.0; p = 0.08; SF-36/Role Physical 100 ± 0.0 vs. 41.7 ± 13.9; p < 0.001). Patients with macro-abscess (CDD 2b) had a better long-term QoL when they were operated (GIQLI 89.3 ± 1.4 vs. 69.5 ± 4.5; p < 0.01; CGQL 80.3 ± 7.6 vs. 60.5 ± 5.8; p < 0.05; SF-36/Role Physical 95.8 ± 4.2 vs. 47.9 ± 13.6; p < 0.001). CONCLUSION: Considering long-term QoL, phlegmonous AD (HS type 2a, Hinchey Ia and CDD 1b, respectively) should be treated conservatively. In patients with covered perforation, abscess size should guide the decision on whether to perform surgery later on or not. In the light of long-term quality of life, patients fare better after elective sigmoid colectomy when abscess size exceeds 1 cm.
PURPOSE: It is controversial whether patients fare better with conservative or surgical treatment in certain stages of acute diverticulitis (AD), in particular when phlegmonous inflammation or covered micro- or macro-perforation are present. The aim of this study was to determine long-term quality of life (QoL) for ADpatients who received either surgery or conservative treatment in different stages. METHODS: We included patients treated for AD at the University Hospital Grosshadern, Munich, Germany, between January 1, 2000, and December 31, 2010. Patients were classified by the Hansen and Stock (HS) classification, the modified Hinchey classification, and the German classification of diverticular disease (CDD). Pre-therapeutic staging was based on multidetector computed tomography. Long-term QoL was assessed by the Cleveland Global Quality of Life (CGQL) questionnaire, the Short Form 36 (SF-36), and the Gastrointestinal Quality of Life Index (GIQLI). Data are mean ± SEM. RESULTS:Patients with phlegmonous AD (HS type 2a, Hinchey Ia and CDD 1b, respectively) had a better long-term QoL on the GIQLI when they were operated (78.5 ± 2.5 vs. 70.7 ± 2.1; p < 0.05). Patients with micro-abscess (CDD 2a) had a better long-term QoL on the GIQLI, CGQL, and the "Role Physical" scale of the SF-36 when they were not operated (GIQLI 86.9 ± 2.1 vs. 76.8 ± 1.0; p = 0.10; CGQL 82.8 ± 5.1 vs. 65.3 ± 11.0; p = 0.08; SF-36/Role Physical 100 ± 0.0 vs. 41.7 ± 13.9; p < 0.001). Patients with macro-abscess (CDD 2b) had a better long-term QoL when they were operated (GIQLI 89.3 ± 1.4 vs. 69.5 ± 4.5; p < 0.01; CGQL 80.3 ± 7.6 vs. 60.5 ± 5.8; p < 0.05; SF-36/Role Physical 95.8 ± 4.2 vs. 47.9 ± 13.6; p < 0.001). CONCLUSION: Considering long-term QoL, phlegmonous AD (HS type 2a, Hinchey Ia and CDD 1b, respectively) should be treated conservatively. In patients with covered perforation, abscess size should guide the decision on whether to perform surgery later on or not. In the light of long-term quality of life, patients fare better after elective sigmoid colectomy when abscess size exceeds 1 cm.
Entities:
Keywords:
Diverticular disease; German classification of diverticular disease; Hansen and stock classification; Quality of life; Sigmoid diverticulitis
Authors: L Leifeld; C T Germer; S Böhm; F L Dumoulin; W Häuser; M Kreis; J Labenz; B Lembcke; S Post; M Reinshagen; J-P Ritz; T Sauerbruch; T Wedel; B von Rahden; W Kruis Journal: Z Gastroenterol Date: 2014-07-15 Impact factor: 2.000
Authors: Caroline S Andeweg; Irene M Mulder; Richelle J F Felt-Bersma; Annelies Verbon; Gert Jan van der Wilt; Harry van Goor; Johan F Lange; Jaap Stoker; Marja A Boermeester; Robert P Bleichrodt Journal: Dig Surg Date: 2013-08-20 Impact factor: 2.588
Authors: Bastiaan R Klarenbeek; Niels de Korte; Donald L van der Peet; Miguel A Cuesta Journal: Int J Colorectal Dis Date: 2011-09-17 Impact factor: 2.571
Authors: Karmina K Choi; Jessica Martinolich; Jonathan J Canete; Brian T Valerian; David A Chismark; Ashar Ata; Edward C Lee Journal: J Gastrointest Surg Date: 2019-01-22 Impact factor: 3.452
Authors: Johan Friso Lock; Christian Galata; Christoph Reißfelder; Jörg-Peter Ritz; Thomas Schiedeck; Christoph-Thomas Germer Journal: Dtsch Arztebl Int Date: 2020-08-31 Impact factor: 5.594
Authors: Johannes C Lauscher; Johan F Lock; Katja Aschenbrenner; Rahel M Strobel; Marja Leonhardt; Andrea Stroux; Benjamin Weixler; Christoph-Thomas Germer; Martin E Kreis Journal: Int J Colorectal Dis Date: 2020-09-04 Impact factor: 2.571